Boswellia, 100mg 60 vcaps - Life Extension
Couldn't load pickup availability
Share
Boswellia, 100mg - 60 vcaps - Life Extension
Compounds in Boswellia extract have been shown to bind directly to 5-LOX, an enzyme that transforms fatty acids into inflammatory factors like leukotriene B4. A compound in boswellia called AKBA is the key to this beneficial action. Each 100 mg vegetarian capsule of Boswellia is standardized to provide 20% of active AKBA from boswellia.
AprèsFlex® absorbs 52% more than standard boswellia extract and is standardized for the active AKBA compound.
5-lipoxygenase (5-LOX) is an enzyme that transforms fatty acids into leukotrienes. Since 5-LOX levels increase over time, excess 5-LOX has been linked to some of the common effects of normal aging.
Boswellia extract inhibits 5-LOX
The Indian plant Boswellia serrata contains compounds shown to inhibit 5-LOX to support joint and arterial health. Boswellia inhibits 5-LOX at the cellular level. Scientific data reveals that a compound in boswellia called AKBA (3-O-acetyl-11-keto-ß-boswellic acid) is the key to this beneficial action.
But boswellia compounds are poorly absorbed into the blood. For this reason, we’ve used AprèsFlex®, a standardized form of boswellia extract. AprèsFlex® absorbs into the blood 52% more than previously available boswellia extracts.
Dietary factors increase 5-LOX prevalence
The typical American diet adds to 5-LOX levels. Foods rich in omega-6 fatty acids like red meat, poultry, eggs and dairy products, along with high-glycemic carbohydrates, trigger production of arachidonic acid. The body produces 5-LOX enzyme in response to arachidonic acid.
Benefits of modulating 5-LOX
5-LOX creates compounds like leukotriene B4 out of arachidonic acid. Inhibiting leukotriene B4 helps support joint, arterial and tissue health. Inhibiting 5-LOX also helped support healthy cell division in preclinical models.
Each 100 mg vegetarian capsule of 5-LOX Inhibitor with AprèsFlex® is standardized to provide 20% of active AKBA from boswellia. Most people need only one capsule a day.
AprèsFlex® is a registered trademark of Laila Nutraceuticals exclusively licensed to PL Thomas – Laila Nutra LLC. International patents pending. |
||||||||||
Dosage and use |
||||||||||
|
||||||||||
Warnings |
||||||||||
|
||||||||||
